Arkema has announced new investments of some €300 million in biosourced polyamide 11 chain in Asia, in a bid to increase its production capacities in the region.
The new investments that will be made over a period of five years will increase Arkema’s polyamide 11 global production capacities by 50 percent.
The investments include a world-scale plant dedicated to producing Rilsan® PA11 biosourced polyamide from castor oil. The new facility, expected to come on stream in late 2021, will be producing amino 11 monomer as well as its polymer, Rilsan® PA11. The new plant will enable Arkema to increase its Rilsan® PA11 (powder and granule) production capacity by 50% while its global production capacities for Pebax® (in particular Pebax® RNew of which amino 11 is a key component) will also increase by 50%.
Rilsan® PA11 is the only high performance 100% biosourced polyamide that qualifies for the most exacting applications particularly for electronics, 3D-printing and automotive markets, where it serves as a metal substitute.
The new investments shows Arkema’s commitment to meet demand for biosourced solutions in Asia and address challenges of lightweighting and design of materials.
More about biobased chemicals production and demand at CMT’s 7th Biobased Chemicals and Plastics
on 5-8 June, 2018
For more information, Contact Grace Oh at email@example.com
or call +65 6346 9147. Read more>>>